Skip to main content
. 2022 Aug 8;34(1):33. doi: 10.1186/s43046-022-00137-0

Fig. 3.

Fig. 3

Pictorial representation of diverge mechanisms of action of ritonavir in different cancers. Ritonavir is thought to apply its anti-cancer action by hindering numerous signaling pathways, including the AKT and nuclear factor-kappa B pathways; it also inhibits survivin, HSP90 substrates and induces ER stress and apoptosis by blocking Akt pathways in various cancers